CERC-501 - CAS# 1174130-61-0 60224 Activation of the PI3K/mTOR pathway

Activation of the PI3K/mTOR pathway promotes cell growth

with AC50 of 0

9(5):319-25

LCB01-0371 was more active than linezolid against these systemic infections

transformation

CERC-501 - CAS# 1174130-61-0 60224 Activation of the PI3K/mTOR pathwayCERC 501, also known as JNJ 67953964, LY 2456302 and Aticaprant, CAS No. 1174130 61 0, is a potent, selective, short acting antagonist of the opioid receptor (KOR) (Ki = 0. 81 nM vs. 24. 0 nM and 155 nM for the opioid receptor (MOR) and opioid receptor (DOR). Aticaprant is under development for the treatment of major depressive disorder and substance use disorders including alcoholism, nicotine addiction, and illicit drug dependence. Aticaprant has